Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation
- PMID: 10022819
- DOI: 10.1038/sj.onc.1202418
Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation
Abstract
The aetiology of sporadic medullary thyroid carcinoma is unknown. About 50% harbour a somatic mutation at codon 918 of RET (M918T). To investigate whether other RET sequence variants may be associated with or predispose to the development of sporadic medullary thyroid carcinoma, we analysed genomic DNA from the germline and corresponding tumour from 50 patients to identify RET sequence variants. In one patient, tumour DNA showed a novel somatic 12 bp in-frame deletion in exon 15. More interestingly, we found that the rare polymorphism at codon 836 (c.2439C > T; S836S) occurred at a significantly higher frequency than that in control individuals without sporadic medullary thyroid carcinoma (Fisher's exact test, P = 0.03). Further, among the nine evaluable cases with germline c.2439C/T, eight also had the somatic M918T mutation in MTC DNA which was more frequent than in patients with the more common c.2439C/C (89% vs 40%, respectively; Fisher's exact test, P = 0.01). These findings suggest that the rare sequence variant at codon 836 may somehow play a role in the genesis of sporadic medullary thyroid carcinoma.
Similar articles
-
Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population.Clin Endocrinol (Oxf). 2001 Sep;55(3):399-402. doi: 10.1046/j.1365-2265.2001.01328.x. Clin Endocrinol (Oxf). 2001. PMID: 11589684
-
Rudolf-Virchow-Preis 1995. The role of RET proto-oncogene mutation analysis in the diagnosis of multiple endocrine neoplasia type 2 (MEN 2) gene carriers and in the discrimination of sporadic and familial medullary thyroid carcinomas and pheochromocytomas.Verh Dtsch Ges Pathol. 1995;79:L-LV. Verh Dtsch Ges Pathol. 1995. PMID: 8600671
-
Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".Int J Cancer. 1996 Aug 22;69(4):312-6. doi: 10.1002/(SICI)1097-0215(19960822)69:4<312::AID-IJC13>3.0.CO;2-7. Int J Cancer. 1996. PMID: 8797874
-
RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.Horm Res. 1997;47(4-6):168-78. doi: 10.1159/000185461. Horm Res. 1997. PMID: 9167949 Review.
-
Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease.Hum Mutat. 1997;9(2):97-109. doi: 10.1002/(SICI)1098-1004(1997)9:2<97::AID-HUMU1>3.0.CO;2-M. Hum Mutat. 1997. PMID: 9067749 Review.
Cited by
-
RET polymorphisms and sporadic medullary thyroid carcinoma in a Portuguese population.Endocrine. 2005 Aug;27(3):239-43. doi: 10.1385/ENDO:27:3:239. Endocrine. 2005. PMID: 16230779
-
Advanced medullary thyroid cancer: pathophysiology and management.Cancer Manag Res. 2013 May 8;5:57-66. doi: 10.2147/CMAR.S33105. Print 2013. Cancer Manag Res. 2013. PMID: 23696715 Free PMC article.
-
Modifier Role of Common RET Variants in Sporadic Medullary Thyroid Carcinoma.Int J Mol Sci. 2021 Oct 30;22(21):11794. doi: 10.3390/ijms222111794. Int J Mol Sci. 2021. PMID: 34769224 Free PMC article. Clinical Trial.
-
Genetic risk association of CDKN1A and RET gene SNPs with medullary thyroid carcinoma: Results from the largest MTC cohort and meta-analysis.Cancer Med. 2019 Oct;8(13):6151-6161. doi: 10.1002/cam4.2443. Epub 2019 Aug 13. Cancer Med. 2019. PMID: 31408923 Free PMC article.
-
Specific haplotypes of the RET proto-oncogene are over-represented in patients with sporadic papillary thyroid carcinoma.J Med Genet. 2002 Apr;39(4):260-5. doi: 10.1136/jmg.39.4.260. J Med Genet. 2002. PMID: 11950855 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases